Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Emerging Treatment Strategies for Refractory Metastatic Breast Cancer
Link ID 3042
Title Emerging Treatment Strategies for Refractory Metastatic Breast Cancer
Url http://www.medscape.com/viewarticle/569417?src=rss
Description In this Expert Interview from SABCS 2007, Dr. Linda Vahdat talks about new drugs and strategies that represent important trends in breast cancer treatment.
Medscape Hematology-Oncology
Category Articles > Hematology-Oncology
Keywords
Date Feb 7, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. African American Women Less Likely to Undergo BRCA1/2 Genetic Testing
  In general, African American women are less likely than white women to pursue genetic testing for BRCA1/2, researchers report. However, African American women with a recent diagnosis of breast cancer are much more likely to do so, according to the article in the January 1st issue of the Journal of Clinical Oncology. Reuters Health Information
Category:   Articles > Hematology-Oncology


2. 10th World Congress on Gastrointestinal Cancer
  Read clinically focused news coverage of key developments from the meeting. Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


3. Needle Core Biopsy Characteristics Identify Patients At Risk of Compromised Margins in Breast Conser
  This study investigates the value of needle core biopsy findings, in particular, the relative quantity of ductal carcinoma in situ, in improving patient selection for breast conservation.
Modern Pathology
Category:   Articles > Hematology-Oncology


4. Evolving Role of mTOR Inhibition in the Treatment of Renal Cell Carcinoma: An Expert Interview With
  In this Expert Interview from ASCO 2008, Dr. Robert Motzer discusses the evolving role of mTOR inhibition in the treatment of renal cell carcinoma, with a focus on the newest agent in the class.
Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


5. European Regulators Say Transfusions Safer Than ESAs in Cancer
  In a startling recommendation, the European Medicines Agency is urging oncologists to favor transfusions over erythropoiesis-stimulating agents. Medscape Medical News
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS